[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@BJLinvestment](/creator/twitter/BJLinvestment) "✅Increasing $HROW: from compounding pharmacy to eye-care leader. VEVYE outpacing CEQUA aiming to dethrone Restasis. Revenue $49M$200M$280M gross margin 6874%. 2025: entering retina debt refinance acquisitions. Niche + unique products + growth = compelling risk/reward" [X Link](https://x.com/BJLinvestment/status/1976593346291261722) [@BJLinvestment](/creator/x/BJLinvestment) 2025-10-10T10:19Z XXX followers, 2775 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BJLinvestment
"✅Increasing $HROW: from compounding pharmacy to eye-care leader. VEVYE outpacing CEQUA aiming to dethrone Restasis. Revenue $49M$200M$280M gross margin 6874%. 2025: entering retina debt refinance acquisitions. Niche + unique products + growth = compelling risk/reward"
X Link @BJLinvestment 2025-10-10T10:19Z XXX followers, 2775 engagements
/creator/twitter::1932923246115946500/posts